APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio-based Hemostatic Powder

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bio-based Hemostatic Powder Market Analysis and Forecast 2026-2032

27 December 2025198 pages

Choose your research edition.

Industry ResearchBio-based Hemostatic Powder Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio-based Hemostatic Powder Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Bio-based Hemostatic Powder Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio-based Hemostatic Powder Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio-based Hemostatic Powder Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Bio-based Hemostatic Powder market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bio-based Hemostatic Powder is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bio-based Hemostatic Powder is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bio-based Hemostatic Powder is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bio-based Hemostatic Powder is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Bio-based Hemostatic Powder include BD, Lanhine Medical, Yancheng Yankang Medical Equipment, Success Bio-Tech, Johnson & Johnson, Haiyuan Hairun, Beijing Aitekang Medical Technology, Baxter and Medtronic, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Bio-based Hemostatic Powder, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bio-based Hemostatic Powder, also provides the sales of main regions and countries. Of the upcoming market potential for Bio-based Hemostatic Powder, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bio-based Hemostatic Powder sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bio-based Hemostatic Powder market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Bio-based Hemostatic Powder sales, projected growth trends, production technology, application and end-user industry.

Bio-based Hemostatic Powder Segment by Company

BD

Lanhine Medical

Yancheng Yankang Medical Equipment

Success Bio-Tech

Johnson & Johnson

Haiyuan Hairun

Beijing Aitekang Medical Technology

Baxter

Medtronic

MedTrade Products

Hemostasis

BioCer Entwicklungs-GmbH

Bio-based Hemostatic Powder Segment by Type

Oxidized Cellulose

Polysaccharides

Other

Bio-based Hemostatic Powder Segment by Application

Surgery

First Aid

Bio-based Hemostatic Powder Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio-based Hemostatic Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio-based Hemostatic Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio-based Hemostatic Powder.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Bio-based Hemostatic Powder in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Bio-based Hemostatic Powder manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bio-based Hemostatic Powder sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bio-based Hemostatic Powder Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oxidized Cellulose Major Manufacturers Table 3. Polysaccharides Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Bio-based Hemostatic Powder Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Surgery Major Manufacturers Table 7. First Aid Major Manufacturers Table 8. Bio-based Hemostatic Powder Industry Trends Table 9. Bio-based Hemostatic Powder Industry Drivers Table 10. Bio-based Hemostatic Powder Industry Opportunities and Challenges Table 11. Bio-based Hemostatic Powder Industry Restraints Table 12. Global Bio-based Hemostatic Powder Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Bio-based Hemostatic Powder Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Bio-based Hemostatic Powder Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Bio-based Hemostatic Powder Revenue Market Share by Region (2021-2026) Table 16. Global Bio-based Hemostatic Powder Revenue Market Share by Region (2027-2032) Table 17. Global Bio-based Hemostatic Powder Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 18. Global Bio-based Hemostatic Powder Sales by Region (2021-2026) & (Units) Table 19. Global Bio-based Hemostatic Powder Sales by Region (2027-2032) & (Units) Table 20. Global Bio-based Hemostatic Powder Sales Market Share by Region (2021-2026) Table 21. Global Bio-based Hemostatic Powder Sales Market Share by Region (2027-2032) Table 22. Global Bio-based Hemostatic Powder Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Bio-based Hemostatic Powder Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Bio-based Hemostatic Powder Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Bio-based Hemostatic Powder Sales Market Share by Manufacturers (2021-2026) Table 26. Global Bio-based Hemostatic Powder Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Bio-based Hemostatic Powder Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Bio-based Hemostatic Powder Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Bio-based Hemostatic Powder Manufacturers, Product Type & Application Table 30. Global Bio-based Hemostatic Powder Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Bio-based Hemostatic Powder by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Bio-based Hemostatic Powder Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Bio-based Hemostatic Powder Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Bio-based Hemostatic Powder Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021-2026) Table 37. Global Bio-based Hemostatic Powder Revenue Market Share by Type (2027-2032) Table 38. Global Bio-based Hemostatic Powder Sales by Type 2021 VS 2025 VS 2032 (Units) Table 39. Global Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 40. Global Bio-based Hemostatic Powder Sales by Type (2027-2032) & (Units) Table 41. Global Bio-based Hemostatic Powder Sales Market Share by Type (2021-2026) Table 42. Global Bio-based Hemostatic Powder Sales Market Share by Type (2027-2032) Table 43. Global Bio-based Hemostatic Powder Price by Type (2021-2026) & (US$/Unit) Table 44. Global Bio-based Hemostatic Powder Price by Type (2027-2032) & (US$/Unit) Table 45. Global Bio-based Hemostatic Powder Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Bio-based Hemostatic Powder Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Bio-based Hemostatic Powder Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Bio-based Hemostatic Powder Revenue Market Share by Application (2021-2026) Table 49. Global Bio-based Hemostatic Powder Revenue Market Share by Application (2027-2032) Table 50. Global Bio-based Hemostatic Powder Sales by Application 2021 VS 2025 VS 2032 (Units) Table 51. Global Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 52. Global Bio-based Hemostatic Powder Sales by Application (2027-2032) & (Units) Table 53. Global Bio-based Hemostatic Powder Sales Market Share by Application (2021-2026) Table 54. Global Bio-based Hemostatic Powder Sales Market Share by Application (2027-2032) Table 55. Global Bio-based Hemostatic Powder Price by Application (2021-2026) & (US$/Unit) Table 56. Global Bio-based Hemostatic Powder Price by Application (2027-2032) & (US$/Unit) Table 57. BD Company Information Table 58. BD Business Overview Table 59. BD Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. BD Bio-based Hemostatic Powder Product Portfolio Table 61. BD Recent Development Table 62. Lanhine Medical Company Information Table 63. Lanhine Medical Business Overview Table 64. Lanhine Medical Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Lanhine Medical Bio-based Hemostatic Powder Product Portfolio Table 66. Lanhine Medical Recent Development Table 67. Yancheng Yankang Medical Equipment Company Information Table 68. Yancheng Yankang Medical Equipment Business Overview Table 69. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolio Table 71. Yancheng Yankang Medical Equipment Recent Development Table 72. Success Bio-Tech Company Information Table 73. Success Bio-Tech Business Overview Table 74. Success Bio-Tech Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Success Bio-Tech Bio-based Hemostatic Powder Product Portfolio Table 76. Success Bio-Tech Recent Development Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Bio-based Hemostatic Powder Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. Haiyuan Hairun Company Information Table 83. Haiyuan Hairun Business Overview Table 84. Haiyuan Hairun Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolio Table 86. Haiyuan Hairun Recent Development Table 87. Beijing Aitekang Medical Technology Company Information Table 88. Beijing Aitekang Medical Technology Business Overview Table 89. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolio Table 91. Beijing Aitekang Medical Technology Recent Development Table 92. Baxter Company Information Table 93. Baxter Business Overview Table 94. Baxter Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Baxter Bio-based Hemostatic Powder Product Portfolio Table 96. Baxter Recent Development Table 97. Medtronic Company Information Table 98. Medtronic Business Overview Table 99. Medtronic Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Medtronic Bio-based Hemostatic Powder Product Portfolio Table 101. Medtronic Recent Development Table 102. MedTrade Products Company Information Table 103. MedTrade Products Business Overview Table 104. MedTrade Products Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. MedTrade Products Bio-based Hemostatic Powder Product Portfolio Table 106. MedTrade Products Recent Development Table 107. Hemostasis Company Information Table 108. Hemostasis Business Overview Table 109. Hemostasis Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Hemostasis Bio-based Hemostatic Powder Product Portfolio Table 111. Hemostasis Recent Development Table 112. BioCer Entwicklungs-GmbH Company Information Table 113. BioCer Entwicklungs-GmbH Business Overview Table 114. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolio Table 116. BioCer Entwicklungs-GmbH Recent Development Table 117. North America Bio-based Hemostatic Powder Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Bio-based Hemostatic Powder Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 120. North America Bio-based Hemostatic Powder Sales by Type (2027-2032) & (Units) Table 121. North America Bio-based Hemostatic Powder Sales Price by Type (2021-2026) & (US$/Unit) Table 122. North America Bio-based Hemostatic Powder Sales Price by Type (2027-2032) & (US$/Unit) Table 123. North America Bio-based Hemostatic Powder Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Bio-based Hemostatic Powder Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 126. North America Bio-based Hemostatic Powder Sales by Application (2027-2032) & (Units) Table 127. North America Bio-based Hemostatic Powder Sales Price by Application (2021-2026) & (US$/Unit) Table 128. North America Bio-based Hemostatic Powder Sales Price by Application (2027-2032) & (US$/Unit) Table 129. North America Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Bio-based Hemostatic Powder Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Bio-based Hemostatic Powder Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 133. North America Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 134. North America Bio-based Hemostatic Powder Sales by Country (2027-2032) & (Units) Table 135. North America Bio-based Hemostatic Powder Sales Price by Country (2021-2026) & (US$/Unit) Table 136. North America Bio-based Hemostatic Powder Sales Price by Country (2027-2032) & (US$/Unit) Table 137. United States Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 138. Canada Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 139. Mexico Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 140. Europe Bio-based Hemostatic Powder Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Bio-based Hemostatic Powder Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 143. Europe Bio-based Hemostatic Powder Sales by Type (2027-2032) & (Units) Table 144. Europe Bio-based Hemostatic Powder Sales Price by Type (2021-2026) & (US$/Unit) Table 145. Europe Bio-based Hemostatic Powder Sales Price by Type (2027-2032) & (US$/Unit) Table 146. Europe Bio-based Hemostatic Powder Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Bio-based Hemostatic Powder Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 149. Europe Bio-based Hemostatic Powder Sales by Application (2027-2032) & (Units) Table 150. Europe Bio-based Hemostatic Powder Sales Price by Application (2021-2026) & (US$/Unit) Table 151. Europe Bio-based Hemostatic Powder Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Europe Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Bio-based Hemostatic Powder Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Bio-based Hemostatic Powder Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 156. Europe Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 157. Europe Bio-based Hemostatic Powder Sales by Country (2027-2032) & (Units) Table 158. Europe Bio-based Hemostatic Powder Sales Price by Country (2021-2026) & (US$/Unit) Table 159. Europe Bio-based Hemostatic Powder Sales Price by Country (2027-2032) & (US$/Unit) Table 160. Germany Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 161. France Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 162. U.K. Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 163. Italy Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 164. Russia Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 165. Spain Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 168. Sweden Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 169. Poland Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 170. China Bio-based Hemostatic Powder Revenue by Type (2021-2026) & (US$ Million) Table 171. China Bio-based Hemostatic Powder Revenue by Type (2027-2032) & (US$ Million) Table 172. China Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 173. China Bio-based Hemostatic Powder Sales by Type (2027-2032) & (Units) Table 174. China Bio-based Hemostatic Powder Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Bio-based Hemostatic Powder Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Bio-based Hemostatic Powder Revenue by Application (2021-2026) & (US$ Million) Table 177. China Bio-based Hemostatic Powder Revenue by Application (2027-2032) & (US$ Million) Table 178. China Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 179. China Bio-based Hemostatic Powder Sales by Application (2027-2032) & (Units) Table 180. China Bio-based Hemostatic Powder Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Bio-based Hemostatic Powder Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Bio-based Hemostatic Powder Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Bio-based Hemostatic Powder Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 185. Asia Bio-based Hemostatic Powder Sales by Type (2027-2032) & (Units) Table 186. Asia Bio-based Hemostatic Powder Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Bio-based Hemostatic Powder Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Bio-based Hemostatic Powder Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Bio-based Hemostatic Powder Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 191. Asia Bio-based Hemostatic Powder Sales by Application (2027-2032) & (Units) Table 192. Asia Bio-based Hemostatic Powder Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Bio-based Hemostatic Powder Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Bio-based Hemostatic Powder Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Bio-based Hemostatic Powder Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 198. Asia Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 199. Asia Bio-based Hemostatic Powder Sales by Country (2027-2032) & (Units) Table 200. Asia Bio-based Hemostatic Powder Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Bio-based Hemostatic Powder Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 203. South Korea Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 204. India Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 205. Australia Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Bio-based Hemostatic Powder Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Bio-based Hemostatic Powder Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Bio-based Hemostatic Powder Sales by Type (2021-2026) & (Units) Table 211. SAMEA Bio-based Hemostatic Powder Sales by Type (2027-2032) & (Units) Table 212. SAMEA Bio-based Hemostatic Powder Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Bio-based Hemostatic Powder Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Bio-based Hemostatic Powder Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Bio-based Hemostatic Powder Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Bio-based Hemostatic Powder Sales by Application (2021-2026) & (Units) Table 217. SAMEA Bio-based Hemostatic Powder Sales by Application (2027-2032) & (Units) Table 218. SAMEA Bio-based Hemostatic Powder Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Bio-based Hemostatic Powder Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Bio-based Hemostatic Powder Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Bio-based Hemostatic Powder Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 224. SAMEA Bio-based Hemostatic Powder Sales by Country (2021-2026) & (Units) Table 225. SAMEA Bio-based Hemostatic Powder Sales by Country (2027-2032) & (Units) Table 226. SAMEA Bio-based Hemostatic Powder Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Bio-based Hemostatic Powder Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 229. Argentina Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 230. Chile Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 231. Colombia Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 232. Peru Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 234. Israel Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 235. UAE Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 236. Turkey Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 237. Iran Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 238. Egypt Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Bio-based Hemostatic Powder Distributors List Table 242. Bio-based Hemostatic Powder Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Bio-based Hemostatic Powder Image Figure 2. Global Bio-based Hemostatic Powder Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio-based Hemostatic Powder Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oxidized Cellulose Image Figure 5. Polysaccharides Image Figure 6. Other Image Figure 7. Global Bio-based Hemostatic Powder Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Bio-based Hemostatic Powder Market Size Share 2021 VS 2025 VS 2032 Figure 9. Surgery Image Figure 10. First Aid Image Figure 11. Global Bio-based Hemostatic Powder Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Bio-based Hemostatic Powder Revenue (2021-2032) & (US$ Million) Figure 13. Global Bio-based Hemostatic Powder Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Bio-based Hemostatic Powder Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Bio-based Hemostatic Powder Revenue Market Share by Region (2021-2032) Figure 16. Global Bio-based Hemostatic Powder Sales (2021-2032) & (Units) Figure 17. Global Bio-based Hemostatic Powder Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 18. Global Bio-based Hemostatic Powder Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Bio-based Hemostatic Powder Sales YoY (2021-2032) & (Units) Figure 20. Europe Bio-based Hemostatic Powder Sales YoY (2021-2032) & (Units) Figure 21. China Bio-based Hemostatic Powder Sales YoY (2021-2032) & (Units) Figure 22. Asia (Excluding China) Bio-based Hemostatic Powder Sales YoY (2021-2032) & (Units) Figure 23. South America, Middle East and Africa Bio-based Hemostatic Powder Sales YoY (2021-2032) & (Units) Figure 24. Global Bio-based Hemostatic Powder Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Bio-based Hemostatic Powder Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Bio-based Hemostatic Powder Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Bio-based Hemostatic Powder Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021-2032) Figure 30. Global Bio-based Hemostatic Powder Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 31. Global Bio-based Hemostatic Powder Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Bio-based Hemostatic Powder Sales Market Share by Type (2021-2032) Figure 33. Global Bio-based Hemostatic Powder Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Bio-based Hemostatic Powder Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Bio-based Hemostatic Powder Revenue Market Share by Application (2021-2032) Figure 36. Global Bio-based Hemostatic Powder Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 37. Global Bio-based Hemostatic Powder Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Bio-based Hemostatic Powder Sales Market Share by Application (2021-2032) Figure 39. North America Bio-based Hemostatic Powder Revenue Share by Type (2021-2032) Figure 40. North America Bio-based Hemostatic Powder Sales Share by Type (2021-2032) Figure 41. North America Bio-based Hemostatic Powder Revenue Share by Application (2021-2032) Figure 42. North America Bio-based Hemostatic Powder Sales Share by Application (2021-2032) Figure 43. North America Bio-based Hemostatic Powder Revenue Share by Country (2021-2032) Figure 44. North America Bio-based Hemostatic Powder Sales Share by Country (2021-2032) Figure 45. Europe Bio-based Hemostatic Powder Revenue Share by Type (2021-2032) Figure 46. Europe Bio-based Hemostatic Powder Sales Share by Type (2021-2032) Figure 47. Europe Bio-based Hemostatic Powder Revenue Share by Application (2021-2032) Figure 48. Europe Bio-based Hemostatic Powder Sales Share by Application (2021-2032) Figure 49. Europe Bio-based Hemostatic Powder Revenue Share by Country (2021-2032) Figure 50. Europe Bio-based Hemostatic Powder Sales Share by Country (2021-2032) Figure 51. China Bio-based Hemostatic Powder Revenue Share by Type (2021-2032) Figure 52. China Bio-based Hemostatic Powder Sales Share by Type (2021-2032) Figure 53. China Bio-based Hemostatic Powder Revenue Share by Application (2021-2032) Figure 54. China Bio-based Hemostatic Powder Sales Share by Application (2021-2032) Figure 55. Asia Bio-based Hemostatic Powder Revenue Share by Type (2021-2032) Figure 56. Asia Bio-based Hemostatic Powder Sales Share by Type (2021-2032) Figure 57. Asia Bio-based Hemostatic Powder Revenue Share by Application (2021-2032) Figure 58. Asia Bio-based Hemostatic Powder Sales Share by Application (2021-2032) Figure 59. Asia Bio-based Hemostatic Powder Revenue Share by Country (2021-2032) Figure 60. Asia Bio-based Hemostatic Powder Sales Share by Country (2021-2032) Figure 61. SAMEA Bio-based Hemostatic Powder Revenue Share by Type (2021-2032) Figure 62. SAMEA Bio-based Hemostatic Powder Sales Share by Type (2021-2032) Figure 63. SAMEA Bio-based Hemostatic Powder Revenue Share by Application (2021-2032) Figure 64. SAMEA Bio-based Hemostatic Powder Sales Share by Application (2021-2032) Figure 65. SAMEA Bio-based Hemostatic Powder Revenue Share by Country (2021-2032) Figure 66. SAMEA Bio-based Hemostatic Powder Sales Share by Country (2021-2032) Figure 67. Bio-based Hemostatic Powder Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Bio-based Hemostatic Powder Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oxidized Cellulose
  • Polysaccharides
  • Other
Applications
  • Surgery
  • First Aid
Companies covered
  • BD
  • Lanhine Medical
  • Yancheng Yankang Medical Equipment
  • Success Bio-Tech
  • Johnson & Johnson
  • Haiyuan Hairun
  • Beijing Aitekang Medical Technology
  • Baxter
  • Medtronic
  • MedTrade Products
  • Hemostasis
  • BioCer Entwicklungs-GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bio-based Hemostatic Powder Market by Type
  3. 1.2.1 Global Bio-based Hemostatic Powder Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oxidized Cellulose
  5. 1.2.3 Polysaccharides
  6. 1.2.4 Other
  7. 1.3 Bio-based Hemostatic Powder Market by Application
  8. 1.3.1 Global Bio-based Hemostatic Powder Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Surgery
  10. 1.3.3 First Aid
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Bio-based Hemostatic Powder Market Dynamics
  1. 2.1 Bio-based Hemostatic Powder Industry Trends
  2. 2.2 Bio-based Hemostatic Powder Industry Drivers
  3. 2.3 Bio-based Hemostatic Powder Industry Opportunities and Challenges
  4. 2.4 Bio-based Hemostatic Powder Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Bio-based Hemostatic Powder Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Bio-based Hemostatic Powder Revenue by Region
  3. 3.2.1 Global Bio-based Hemostatic Powder Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bio-based Hemostatic Powder Revenue by Region (2021-2026)
  5. 3.2.3 Global Bio-based Hemostatic Powder Revenue by Region (2027-2032)
  6. 3.2.4 Global Bio-based Hemostatic Powder Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Bio-based Hemostatic Powder Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Bio-based Hemostatic Powder Sales by Region
  9. 3.4.1 Global Bio-based Hemostatic Powder Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Bio-based Hemostatic Powder Sales by Region (2021-2026)
  11. 3.4.3 Global Bio-based Hemostatic Powder Sales by Region (2027-2032)
  12. 3.4.4 Global Bio-based Hemostatic Powder Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Bio-based Hemostatic Powder Revenue by Manufacturers
  2. 4.1.1 Global Bio-based Hemostatic Powder Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Bio-based Hemostatic Powder Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Bio-based Hemostatic Powder Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bio-based Hemostatic Powder Sales by Manufacturers
  6. 4.2.1 Global Bio-based Hemostatic Powder Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Bio-based Hemostatic Powder Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Bio-based Hemostatic Powder Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Bio-based Hemostatic Powder Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Bio-based Hemostatic Powder Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Bio-based Hemostatic Powder Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Bio-based Hemostatic Powder Manufacturers, Product Type & Application
  13. 4.7 Global Bio-based Hemostatic Powder Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Bio-based Hemostatic Powder Market CR5 and HHI
  16. 4.8.2 2025 Bio-based Hemostatic Powder Tier 1, Tier 2, and Tier 3
5 Bio-based Hemostatic Powder Market by Type
  1. 5.1 Global Bio-based Hemostatic Powder Revenue by Type
  2. 5.1.1 Global Bio-based Hemostatic Powder Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Bio-based Hemostatic Powder Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Bio-based Hemostatic Powder Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Bio-based Hemostatic Powder Sales by Type
  6. 5.2.1 Global Bio-based Hemostatic Powder Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Bio-based Hemostatic Powder Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Bio-based Hemostatic Powder Sales Market Share by Type (2021-2032)
  9. 5.3 Global Bio-based Hemostatic Powder Price by Type
6 Bio-based Hemostatic Powder Market by Application
  1. 6.1 Global Bio-based Hemostatic Powder Revenue by Application
  2. 6.1.1 Global Bio-based Hemostatic Powder Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Bio-based Hemostatic Powder Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Bio-based Hemostatic Powder Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Bio-based Hemostatic Powder Sales by Application
  6. 6.2.1 Global Bio-based Hemostatic Powder Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Bio-based Hemostatic Powder Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Bio-based Hemostatic Powder Sales Market Share by Application (2021-2032)
  9. 6.3 Global Bio-based Hemostatic Powder Price by Application
7 Company Profiles
  1. 7.1 BD
  2. 7.1.1 BD Company Information
  3. 7.1.2 BD Business Overview
  4. 7.1.3 BD Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 BD Bio-based Hemostatic Powder Product Portfolio
  6. 7.1.5 BD Recent Developments
  7. 7.2 Lanhine Medical
  8. 7.2.1 Lanhine Medical Company Information
  9. 7.2.2 Lanhine Medical Business Overview
  10. 7.2.3 Lanhine Medical Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Lanhine Medical Bio-based Hemostatic Powder Product Portfolio
  12. 7.2.5 Lanhine Medical Recent Developments
  13. 7.3 Yancheng Yankang Medical Equipment
  14. 7.3.1 Yancheng Yankang Medical Equipment Company Information
  15. 7.3.2 Yancheng Yankang Medical Equipment Business Overview
  16. 7.3.3 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Yancheng Yankang Medical Equipment Bio-based Hemostatic Powder Product Portfolio
  18. 7.3.5 Yancheng Yankang Medical Equipment Recent Developments
  19. 7.4 Success Bio-Tech
  20. 7.4.1 Success Bio-Tech Company Information
  21. 7.4.2 Success Bio-Tech Business Overview
  22. 7.4.3 Success Bio-Tech Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Success Bio-Tech Bio-based Hemostatic Powder Product Portfolio
  24. 7.4.5 Success Bio-Tech Recent Developments
  25. 7.5 Johnson & Johnson
  26. 7.5.1 Johnson & Johnson Company Information
  27. 7.5.2 Johnson & Johnson Business Overview
  28. 7.5.3 Johnson & Johnson Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Johnson & Johnson Bio-based Hemostatic Powder Product Portfolio
  30. 7.5.5 Johnson & Johnson Recent Developments
  31. 7.6 Haiyuan Hairun
  32. 7.6.1 Haiyuan Hairun Company Information
  33. 7.6.2 Haiyuan Hairun Business Overview
  34. 7.6.3 Haiyuan Hairun Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Haiyuan Hairun Bio-based Hemostatic Powder Product Portfolio
  36. 7.6.5 Haiyuan Hairun Recent Developments
  37. 7.7 Beijing Aitekang Medical Technology
  38. 7.7.1 Beijing Aitekang Medical Technology Company Information
  39. 7.7.2 Beijing Aitekang Medical Technology Business Overview
  40. 7.7.3 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Beijing Aitekang Medical Technology Bio-based Hemostatic Powder Product Portfolio
  42. 7.7.5 Beijing Aitekang Medical Technology Recent Developments
  43. 7.8 Baxter
  44. 7.8.1 Baxter Company Information
  45. 7.8.2 Baxter Business Overview
  46. 7.8.3 Baxter Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Baxter Bio-based Hemostatic Powder Product Portfolio
  48. 7.8.5 Baxter Recent Developments
  49. 7.9 Medtronic
  50. 7.9.1 Medtronic Company Information
  51. 7.9.2 Medtronic Business Overview
  52. 7.9.3 Medtronic Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Medtronic Bio-based Hemostatic Powder Product Portfolio
  54. 7.9.5 Medtronic Recent Developments
  55. 7.10 MedTrade Products
  56. 7.10.1 MedTrade Products Company Information
  57. 7.10.2 MedTrade Products Business Overview
  58. 7.10.3 MedTrade Products Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 MedTrade Products Bio-based Hemostatic Powder Product Portfolio
  60. 7.10.5 MedTrade Products Recent Developments
  61. 7.11 Hemostasis
  62. 7.11.1 Hemostasis Company Information
  63. 7.11.2 Hemostasis Business Overview
  64. 7.11.3 Hemostasis Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hemostasis Bio-based Hemostatic Powder Product Portfolio
  66. 7.11.5 Hemostasis Recent Developments
  67. 7.12 BioCer Entwicklungs-GmbH
  68. 7.12.1 BioCer Entwicklungs-GmbH Company Information
  69. 7.12.2 BioCer Entwicklungs-GmbH Business Overview
  70. 7.12.3 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 BioCer Entwicklungs-GmbH Bio-based Hemostatic Powder Product Portfolio
  72. 7.12.5 BioCer Entwicklungs-GmbH Recent Developments
8 North America
  1. 8.1 North America Bio-based Hemostatic Powder Market Size by Type
  2. 8.1.1 North America Bio-based Hemostatic Powder Revenue by Type (2021-2032)
  3. 8.1.2 North America Bio-based Hemostatic Powder Sales by Type (2021-2032)
  4. 8.1.3 North America Bio-based Hemostatic Powder Price by Type (2021-2032)
  5. 8.2 North America Bio-based Hemostatic Powder Market Size by Application
  6. 8.2.1 North America Bio-based Hemostatic Powder Revenue by Application (2021-2032)
  7. 8.2.2 North America Bio-based Hemostatic Powder Sales by Application (2021-2032)
  8. 8.2.3 North America Bio-based Hemostatic Powder Price by Application (2021-2032)
  9. 8.3 North America Bio-based Hemostatic Powder Market Size by Country
  10. 8.3.1 North America Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Bio-based Hemostatic Powder Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Bio-based Hemostatic Powder Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Bio-based Hemostatic Powder Market Size by Type
  2. 9.1.1 Europe Bio-based Hemostatic Powder Revenue by Type (2021-2032)
  3. 9.1.2 Europe Bio-based Hemostatic Powder Sales by Type (2021-2032)
  4. 9.1.3 Europe Bio-based Hemostatic Powder Price by Type (2021-2032)
  5. 9.2 Europe Bio-based Hemostatic Powder Market Size by Application
  6. 9.2.1 Europe Bio-based Hemostatic Powder Revenue by Application (2021-2032)
  7. 9.2.2 Europe Bio-based Hemostatic Powder Sales by Application (2021-2032)
  8. 9.2.3 Europe Bio-based Hemostatic Powder Price by Application (2021-2032)
  9. 9.3 Europe Bio-based Hemostatic Powder Market Size by Country
  10. 9.3.1 Europe Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Bio-based Hemostatic Powder Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Bio-based Hemostatic Powder Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Bio-based Hemostatic Powder Market Size by Type
  2. 10.1.1 China Bio-based Hemostatic Powder Revenue by Type (2021-2032)
  3. 10.1.2 China Bio-based Hemostatic Powder Sales by Type (2021-2032)
  4. 10.1.3 China Bio-based Hemostatic Powder Price by Type (2021-2032)
  5. 10.2 China Bio-based Hemostatic Powder Market Size by Application
  6. 10.2.1 China Bio-based Hemostatic Powder Revenue by Application (2021-2032)
  7. 10.2.2 China Bio-based Hemostatic Powder Sales by Application (2021-2032)
  8. 10.2.3 China Bio-based Hemostatic Powder Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bio-based Hemostatic Powder Market Size by Type
  2. 11.1.1 Asia Bio-based Hemostatic Powder Revenue by Type (2021-2032)
  3. 11.1.2 Asia Bio-based Hemostatic Powder Sales by Type (2021-2032)
  4. 11.1.3 Asia Bio-based Hemostatic Powder Price by Type (2021-2032)
  5. 11.2 Asia Bio-based Hemostatic Powder Market Size by Application
  6. 11.2.1 Asia Bio-based Hemostatic Powder Revenue by Application (2021-2032)
  7. 11.2.2 Asia Bio-based Hemostatic Powder Sales by Application (2021-2032)
  8. 11.2.3 Asia Bio-based Hemostatic Powder Price by Application (2021-2032)
  9. 11.3 Asia Bio-based Hemostatic Powder Market Size by Country
  10. 11.3.1 Asia Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Bio-based Hemostatic Powder Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Bio-based Hemostatic Powder Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bio-based Hemostatic Powder Market Size by Type
  2. 12.1.1 SAMEA Bio-based Hemostatic Powder Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Bio-based Hemostatic Powder Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Bio-based Hemostatic Powder Price by Type (2021-2032)
  5. 12.2 SAMEA Bio-based Hemostatic Powder Market Size by Application
  6. 12.2.1 SAMEA Bio-based Hemostatic Powder Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Bio-based Hemostatic Powder Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Bio-based Hemostatic Powder Price by Application (2021-2032)
  9. 12.3 SAMEA Bio-based Hemostatic Powder Market Size by Country
  10. 12.3.1 SAMEA Bio-based Hemostatic Powder Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Bio-based Hemostatic Powder Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Bio-based Hemostatic Powder Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Bio-based Hemostatic Powder Value Chain Analysis
  2. 13.1.1 Bio-based Hemostatic Powder Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Bio-based Hemostatic Powder Production Mode & Process
  6. 13.2 Bio-based Hemostatic Powder Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Bio-based Hemostatic Powder Distributors
  9. 13.2.3 Bio-based Hemostatic Powder Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst